Asia (Southeast Asia, China, India) India — UIP performance and adult immunization push Routine childhood coverage in India remains high, with ≥96% of children 12–23 months having received at least one vaccine; notable gains include rotavirus coverage rising from 36.4% to 85.4% and measles second-dose coverage from 58.6% to 71.8%, reinforcing sustained progress under the Universal Immunization Program. In parallel, professional societies continue to promote 2026 adult immunization guidance that simplifies schedules, incorporates newer products such as PCV20, and positions adult vaccination — including cancer-prevention vaccines — as a core preventive strategy. China — Sinovac MDCK cell-based influenza vaccine China’s National Medical Products Administration (NMPA) has granted Sinovac approval to initiate clinical trials of an MDCK cell-based, split-virion inactivated influenza vaccine; Phase 1 is scheduled to commence in 2026, following prior marketing authorization of the same product in the United Arab Emirates. This move positions a major Chinese producer to enter the expanding...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!
